Guardant Health, Inc. (GH) vs Medpace Holdings, Inc. (MEDP)
- Guardant Health, Inc. GH 158.29 −4.58%
- Medpace Holdings, Inc. MEDP 618.47 −1.61%
Guardant Health, Inc. and Medpace Holdings, Inc. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $22.3B against $17.6B — 1.3× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Medpace Holdings, Inc. trades at 35.6×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 24.7%. Medpace Holdings, Inc. has the higher net margin (17.7% vs −38.3%) and the higher return on invested capital (0.00% vs −129.7%). Across the 18 metrics below, Medpace Holdings, Inc. leads on 13 and Guardant Health, Inc. on 5.
Valuation
Profitability
| Metric | GH | MEDP | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.01% | 72.35% | 50.89% |
| Operating margin | (39.75%) | 20.97% | (8.57%) |
| Net margin | (38.33%) | 17.67% | (6.37%) |
| Free cash flow margin | (20.35%) | 25.40% | 0.00% |
| Return on equity | 171.64% | 162.15% | (2.92%) |
| Return on assets | (27.95%) | 27.09% | (6.71%) |
| Return on invested capital | (129.70%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack